Case Series of Nizon‐Isidor Syndrome by Heterozygous Variants in MED12L With Further Evidence of Mitotic Instability in One Case With Diploid–Triploid Mosaicism
American Journal of Medical Genetics Part A · 2026
DOI: 10.1002/ajmg.a.64233 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, 2026. Verfasst von Russell Stewart und 20 weiteren Autor:innen. Beteiligte Einrichtung: Vanderbilt University School of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Mediator Complex, Intellectual Disability, Developmental Disabilities, Abnormalities, Multiple. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NIH HHS, National Institute of Neurological Disorders and Stroke.
Abstract (Originalsprache)
Nizon‐Isidor syndrome is a rare disorder caused by heterozygous variants in MED12L , with only eight documented cases in the literature. Here, we present three additional cases of this syndrome. Proband 1 was a 7‐year‐old female who presented with developmental delay, right‐leg hemihypertrophy, laryngeal cleft, esotropia, abnormal skin pigmentation, sectoral iris hypopigmentation, dysphagia, periventricular nodular heterotopia, seizures, morbid obesity, and a pelvic kidney. Genome sequencing (GS) revealed a MED12L variant, NM_053002.5:c.3559+2T>G. Both computational models and transcriptomic analysis confirmed that this variant induced splice loss of MED12L exon 25. Probands 2 and 3 presented with overlapping phenotypes of developmental delay; sequencing confirmed c.3441_3444dup; p.(G1149Nfs*13) and seq[GRCh37] del(3)(q25.1q25.1) chr3:g.?_151075120 variants affecting MED12L . Further investigation found diploid–triploid mosaicism in Proband 1, supporting the hypothesis that loss of MED12L function may increase risk for other cytogenetic abnormalities. Probands 2 and 3 did not harbor evidence of additional cytogenetic aberrations. In Proband 1, caloric restriction and semaglutide–pramlintide combination therapy were started at age eight and were effective in weight reduction. Overall, this report expands the phenotypic spectrum of Nizon‐Isidor syndrome, highlights a potential link between MED12L and cytogenetic abnormalities, and demonstrates a case of weight loss through GLP‐1 therapy in a child with a genetic obesity syndrome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vanderbilt University School of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- Department of Pediatrics, Division of Medical Genetics and Genomic Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- Department of Pediatrics, Program for Children With Medical Complexity, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- Department of Internal Medicine, Maimonides Medical Center, Brooklyn, New York, USA.
- Division of Diabetes, Endocrinology & Metabolism, Department of Pediatrics and Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
ORCID-Profile: Kimberly M Ezell, Deanna S Bell, Gitanjali Srivastava, Farah A Ladha, Rachel Franciskovich, Thomas Cassini
Förderung
- NINDS NIH HHS
- NIH HHS
- National Institute of Neurological Disorders and Stroke
- National Institutes of Health
Zitieren
APA
Stewart, R., Ezell, K. M., Bell, D. S., Corner, B., McMinn, A., Cogan, J. D., Hamid, R., Rives, L., Phillips, J. A., Paddu, N., Srivastava, G., Marom, R., Ladha, F. A., Soler-Alfonso, C., Franciskovich, R., Koziura, M., Pruthi, S., Richard, G., Sheedy, C. B., …, & Cassini, T. (2026). Case Series of Nizon‐Isidor Syndrome by Heterozygous Variants in MED12L With Further Evidence of Mitotic Instability in One Case With Diploid–Triploid Mosaicism. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.64233
Vancouver
Stewart R, Ezell KM, Bell DS, Corner B, McMinn A, Cogan JD, et al. Case Series of Nizon‐Isidor Syndrome by Heterozygous Variants in MED12L With Further Evidence of Mitotic Instability in One Case With Diploid–Triploid Mosaicism. American Journal of Medical Genetics Part A. 2026. doi:10.1002/ajmg.a.64233
BibTeX
@article{Stewart2026,
author = {Stewart, Russell and Ezell, Kimberly M and Bell, Deanna S and Corner, Brian and McMinn, Ashley and Cogan, Joy D and Hamid, Rizwan and Rives, Lynette and Phillips, John A and Paddu, Nina and Srivastava, Gitanjali and Marom, Ronit and Ladha, Farah A and Soler-Alfonso, Claudia and Franciskovich, Rachel and Koziura, Mary and Pruthi, Sumit and Richard, Gabriele and Sheedy, Christina B and Undiagnosed Diseases Network, Undiagnosed Diseases Network and Cassini, Thomas},
title = {Case Series of Nizon‐Isidor Syndrome by Heterozygous Variants in MED12L With Further Evidence of Mitotic Instability in One Case With Diploid–Triploid Mosaicism},
journal = {American Journal of Medical Genetics Part A},
year = {2026},
doi = {10.1002/ajmg.a.64233}
}
EUVIMED